Pharmalittle: Price of new ALS drug prompts criticism; many drug price hikes exceeded U.S. inflation rate

Moderna refused to hand over to China the core intellectual property behind its Covid-19 vaccine, leading to a collapse in negotiations on its sale there.

Read the full article here

Related Articles